A persistent problem in medicine is the lack of ability to specifically target diseased cells and tissues. Drugs are usually administered as free compounds. This non-specific mode of delivery relies on the drug molecules to serendipitously reach target cells. Nanomedicine refers to the area of science that combines nanotechnology with drugs or diagnostic molecules to improve their ability to target specific cells or tissues. These materials are produced on the nanoscale level and are safe to introduce into the body. Applications for nanomedicine include imaging, diagnosis, and the delivery of drugs that help medical professionals treat various diseases.
Scope
- Nanomedicine is the area of science that combines nanotechnology with drugs or diagnostic molecules to improve their ability to target specific cells or tissues.
- Nanomedicine use is on the rise, and players range from private, smaller companies to larger players that dominate multiple industries.
- Nanotechnologies include liposomes, microbubbles, and nanoparticles.
Reasons to Buy
- Understand the nanomedicine market and how different technologies and therapies are used.
- Learn which players are dominant in the different nanomedicine markets.
- Understand the different trends and events that are impacting the nanomedicine market.
Table of Contents
- Executive Summary
- Players
- Technology Briefing
- Trends
- Industry Analysis
- Value Chain
- Companies
- Sector Scorecard
- Glossary
- Further Reading
- Thematic Research Methodology
- About the Analyst
- Contact the Publisher
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- GE Healthcare
- Lantheus
- Dompe
- Johnson & Johnson
- AlfaSigma
- Gilead
- Pacira
- F. Hoffmann-La Roche
- Merck
- Sanofi
- Moderna
- Pfizer
